Patients with retinal vascular occlusion had an elevated risk for Alzheimer’s disease and related dementias, new research shows.

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Researchers have added to a stack of existing evidence that 40 Hz gamma frequencies could help to treat Alzheimer's disease.

"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...

High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. A new JCI Insight study ...

Professional soccer players and American football stars are at much greater risk of developing dementia. What can we do to ...

Most often, caregivers are “told” what they should or could be doing in the care of their loved ones with Alzheimer’s disease ...

I inherited $400,000 and I have absolutely no idea what to do. I’m retired and 72. I’ve been diagnosed with Alzheimer’s ...

Richard Silverman, PhD, is a Northwestern University chemist whose name bears the building. His experimentation led to the ...

More than 7 million people in the U.S. are living with Alzheimer’s disease, and while significant advancements have been made ...

You think you’re fine. Your family and friends think you’re fine. But, just maybe, you’re not. Maybe you already have Alzheimer’s disease, but you just don’t know it yet, because it can begin ...

An experimental Alzheimer's disease drug from Eisai (4523.T) and Biogen (BIIB.O) slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients ...